Selection of a Nuclease-Resistant RNA Aptamer Targeting CD19

SIMPLE SUMMARY: Haematological malignancies show a constantly growing incidence, accounting for 6.5% of new cancer cases worldwide. Among them, B-cell neoplasms often show resistance to conventional chemotherapy that is also associated with numerous adverse effects. Therefore, in order for the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Carla L., Van Roosbroeck, Katrien, Santamaria, Gianluca, Rotoli, Deborah, Sandomenico, Annamaria, Wierda, William G., Ferrajoli, Alessandra, Ruvo, Menotti, Calin, George A., de Franciscis, Vittorio, Catuogno, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533794/
https://www.ncbi.nlm.nih.gov/pubmed/34680368
http://dx.doi.org/10.3390/cancers13205220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533794/
https://www.ncbi.nlm.nih.gov/pubmed/34680368
http://dx.doi.org/10.3390/cancers13205220

Ejemplares similares